DE60336472D1 - Verwendung von Kollagen-Hydrolysat zur Reduktion der Viskosität einer Guarkernmehl enthaltenden Zusammensetzung - Google Patents

Verwendung von Kollagen-Hydrolysat zur Reduktion der Viskosität einer Guarkernmehl enthaltenden Zusammensetzung

Info

Publication number
DE60336472D1
DE60336472D1 DE60336472T DE60336472T DE60336472D1 DE 60336472 D1 DE60336472 D1 DE 60336472D1 DE 60336472 T DE60336472 T DE 60336472T DE 60336472 T DE60336472 T DE 60336472T DE 60336472 D1 DE60336472 D1 DE 60336472D1
Authority
DE
Germany
Prior art keywords
viscosity
reduce
guar gum
containing composition
collagen hydrolyzate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336472T
Other languages
English (en)
Inventor
Nicolas Auriou
Michael Beer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Application granted granted Critical
Publication of DE60336472D1 publication Critical patent/DE60336472D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE60336472T 2002-06-13 2003-06-12 Verwendung von Kollagen-Hydrolysat zur Reduktion der Viskosität einer Guarkernmehl enthaltenden Zusammensetzung Expired - Lifetime DE60336472D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213612.5A GB0213612D0 (en) 2002-06-13 2002-06-13 Organic compounds
PCT/EP2003/006194 WO2003105882A1 (en) 2002-06-13 2003-06-12 Composition comprising viscous fibers and viscosity-lowering proteins

Publications (1)

Publication Number Publication Date
DE60336472D1 true DE60336472D1 (de) 2011-05-05

Family

ID=9938524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336472T Expired - Lifetime DE60336472D1 (de) 2002-06-13 2003-06-12 Verwendung von Kollagen-Hydrolysat zur Reduktion der Viskosität einer Guarkernmehl enthaltenden Zusammensetzung

Country Status (14)

Country Link
US (1) US20060099324A1 (de)
EP (1) EP1515741B1 (de)
JP (2) JP2005534667A (de)
AT (1) ATE502644T1 (de)
AU (1) AU2003242692C1 (de)
CA (1) CA2489250C (de)
DE (1) DE60336472D1 (de)
DK (1) DK1515741T3 (de)
ES (1) ES2363220T3 (de)
GB (1) GB0213612D0 (de)
HK (1) HK1075012A1 (de)
PT (1) PT1515741E (de)
WO (1) WO2003105882A1 (de)
ZA (1) ZA200409528B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) * 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
CN102077854A (zh) 2003-10-16 2011-06-01 泰克康姆集团公司 具有降低的血糖应答的可消化性降低的碳水化合物食物
US7879380B1 (en) * 2003-10-22 2011-02-01 Cybersoft, Inc. Apparatus, methods and articles of manufacture for high conductivity cooking
US8227008B1 (en) * 2003-10-22 2012-07-24 Cybersoft, Inc. Low carbohydrate, functional-like foods and systems incorporating same
US20080221023A1 (en) * 2004-05-27 2008-09-11 Campina Nederland Holding Use of Protein Hydrolysates For the Manufacture of a Medicament For Prophylaxis and/or Treatment of a Dpp-IV Mediated Condition
DK2705849T3 (en) 2004-07-19 2018-05-22 Nutricia Nv Preparation for the use of aspartate for the regulation of blood glucose levels
US20060105021A1 (en) * 2004-09-24 2006-05-18 Remington Direct Lp Cholesterol-reducing liquid
CN101060792B (zh) * 2004-11-19 2012-09-19 帝斯曼知识产权资产管理有限公司 用于活性成分制剂的经改良植物胶
EP1831361B1 (de) 2004-12-23 2012-01-25 Campina Nederland Holding B.V. Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
JP2009517464A (ja) 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
DE102006036285A1 (de) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
FI122915B (fi) * 2006-09-06 2012-08-31 Cerefi Oy Kylläisyyttä aiheuttava tuote
AU2007317780B2 (en) 2006-11-07 2013-06-13 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
FR2912607B1 (fr) * 2007-02-20 2009-10-02 Gervais Danone Sa Produit alimentaire semi-fluide comprenant des fibres de beta-glucane et de la gomme de guar, utilisation en tant qu'aliment fonctionnel
JP2010018522A (ja) * 2007-03-23 2010-01-28 Hiroshima Univ アディポネクチン産生促進剤
US8518469B2 (en) * 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
FR2917948B1 (fr) * 2007-06-29 2010-10-29 Gervais Danone Sa Preparation de fruits stable a forte concentration de gomme d'acacia
JP5456246B2 (ja) * 2007-09-19 2014-03-26 太陽化学株式会社 腹持ち向上食品及びペットフード
KR20120097380A (ko) * 2009-10-31 2012-09-03 솔레 엘엘씨 글루텐이 없는 구조화된 단백질 산물
WO2011112074A1 (en) * 2010-03-11 2011-09-15 N.V. Nutricia Novel glucose tolerance test and composition for use
US9034342B2 (en) * 2010-03-25 2015-05-19 Gateway Health Alliances, Inc Methods and compositions to reduce fat gain, promote weight loss in animals
NZ602949A (en) * 2010-04-12 2014-11-28 Esm Holdings Llc Methods for treating glucose metabolic disorders
WO2012024270A1 (en) * 2010-08-17 2012-02-23 Abbott Laboratories Nutritional composition comprising cereal beta-glucan and salacia extract
AU2013204801B2 (en) * 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
EP2700321A1 (de) * 2012-08-24 2014-02-26 Etablissements J. Soufflet Wässrige Lebensmittelzusammensetzung angereichert mit Beta-Glucan
JP6514636B2 (ja) * 2013-03-07 2019-05-15 大塚食品株式会社 大麦粉末を含む食品
JP5794373B1 (ja) * 2014-10-28 2015-10-14 不二製油株式会社 肉様食感の強い組織状大豆蛋白質素材
WO2015190142A1 (ja) * 2014-06-10 2015-12-17 不二製油グループ本社株式会社 肉様食感の強い組織状大豆蛋白質素材
CN105341561A (zh) * 2014-08-18 2016-02-24 塔特和莱利瑞典公司 具有改善口感的降脂肪组合物
US9936721B2 (en) 2014-08-27 2018-04-10 DuPont Nutrition USA, Inc. Drink stabilizer composition and stabilized drink compositions
JP5746414B1 (ja) * 2014-11-25 2015-07-08 森永製菓株式会社 麺様ゲル状食品用の麺線付着防止剤及び麺様ゲル状食品
UA121122C2 (uk) * 2014-11-26 2020-04-10 Омега Фарма Інновейшн Енд Девелопмент Нв Композиція харчових волокон
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
CN105982038A (zh) * 2015-02-09 2016-10-05 可口可乐公司 用于再造粒的组合物和方法
JP2016154461A (ja) * 2015-02-23 2016-09-01 味の素ゼネラルフーヅ株式会社 粉末状組成物及びスムージー様飲料
US10226063B2 (en) * 2015-10-01 2019-03-12 The United States Of America As Represented By The Secretary Of Agriculture Methods of decreasing the viscosity of a dietary fiber
EP3167895A1 (de) * 2015-11-10 2017-05-17 University College Dublin Nahrungsergänzung enhaltend beta-glukan und caseinhydrolysat zur verbesserung des gesundheits- und wachstumsleistung in einem säugetier
ITUA20163937A1 (it) * 2016-05-30 2017-11-30 Pharcoterm S R L Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.
WO2023218417A1 (en) * 2022-05-12 2023-11-16 The Live Green Group, Inc., Plant-only gums (3) replacement system in food products and methods of preparation thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3889007A (en) * 1973-01-26 1975-06-10 Ocean Food Inc Aquatic animal food composition
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
ZA793769B (en) * 1978-07-25 1981-02-25 Wellcome Found Pharmaceutical formulation of guar gum
JPS56169560A (en) * 1980-05-30 1981-12-26 Tanpei Seiyaku Kk Dietary food
US4478658A (en) * 1982-12-20 1984-10-23 Warner-Lambert Company Method for sealing non-enteric capsules
US5126332A (en) * 1986-09-01 1992-06-30 Terumo Kabushiki Kaisha Food compositions for the prevention of overeating
JPS63185339A (ja) * 1986-09-01 1988-07-30 Terumo Corp 食品用組成物
DK0483070T3 (da) * 1990-10-24 1995-07-17 Sandoz Nutrition Ltd Næringsmæssigt komplet fødevaresammensætning indeholdende hydrolyseret opløselig fiber
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5545411A (en) * 1994-12-16 1996-08-13 Bristol-Myers Squibb Company Method for lowering viscosity by use of gum acacia
JPH104876A (ja) * 1996-06-19 1998-01-13 Calpis Food Ind Co Ltd:The カルシウム入り乳性酸性飲料
JP3720496B2 (ja) * 1996-11-29 2005-11-30 ユニテックフーズ株式会社 新規ペクチン及びそれを含有する乳化液
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
EP0966210A1 (de) * 1997-03-13 1999-12-29 Abbott Laboratories Nahrungszusammensetzung, welche hydrolisierte proteine und ballaststoffmischung enthält
JP4268227B2 (ja) * 1997-03-18 2009-05-27 サンスター株式会社 固体粒子形成用組成物
ES2206821T3 (es) * 1997-06-23 2004-05-16 Societe Des Produits Nestle S.A. Uso de una composicion nutritiva para la preparacion de una composicion liquida para diabeticos.
ES2221014T3 (es) * 1997-06-23 2004-12-16 Societe Des Produits Nestle S.A. Composicion nutritiva que contiene fibras de guisante e inulina.
CA2252691C (en) * 1997-11-07 2005-12-06 Kyowa Hakko Kogyo Co., Ltd. Protein-containing acidic foods and drinks
US6210686B1 (en) * 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US6355609B1 (en) * 1999-04-14 2002-03-12 Nestec S.A. Methods for stabilizing liquid nutritional products and products so stabilized
JP4620819B2 (ja) * 1999-08-25 2011-01-26 味の素株式会社 高カロリー高蛋白質流動食
JP2001120227A (ja) * 1999-10-29 2001-05-08 We'll Corporation:Kk ダイエット食品
KR20020075775A (ko) * 1999-12-16 2002-10-05 시스킨드, 해리 영양제 조성물, 상기 조성물의 제조 방법 및 상기조성물의 사용 방법
JP3907098B2 (ja) * 2001-02-13 2007-04-18 株式会社大塚製薬工場 栄養飲料またはゼリー

Also Published As

Publication number Publication date
DK1515741T3 (da) 2011-07-11
CA2489250A1 (en) 2003-12-24
ZA200409528B (en) 2006-01-25
AU2003242692A1 (en) 2003-12-31
ES2363220T3 (es) 2011-07-27
ATE502644T1 (de) 2011-04-15
EP1515741B1 (de) 2011-03-23
CA2489250C (en) 2013-12-10
WO2003105882A1 (en) 2003-12-24
AU2003242692C1 (en) 2009-06-04
GB0213612D0 (en) 2002-07-24
JP2005534667A (ja) 2005-11-17
EP1515741A1 (de) 2005-03-23
JP2010254702A (ja) 2010-11-11
HK1075012A1 (en) 2005-12-02
PT1515741E (pt) 2011-06-30
US20060099324A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
DE60336472D1 (de) Verwendung von Kollagen-Hydrolysat zur Reduktion der Viskosität einer Guarkernmehl enthaltenden Zusammensetzung
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
BR9913517A (pt) Composição, dispositivo, e, uso de uma composição
ATE250867T1 (de) Verwendung einer nutritiven zusammensetzung zur herstellung einer flüssigen zusammensetzung für diabetiker
DE69523585D1 (de) Wundheilmittel
ATE221094T1 (de) Vernetzbare monomere auf cyclosiloxanbasis, deren herstellung und deren verwendung in polymerisierbaren massen
DE69302823T2 (de) Kieselsäuresole, verfahren zur herstellung von kieselsäuresolen und verwendung von diesen solen
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
TW200735890A (en) Compositions and methods for increasing insulin sensitivity
ATE517932T1 (de) Aus der schmelze verarbeitbare polymerzusammensetzung, die fluorpolymer mit langkettenverzweigungen enthält
PL346520A1 (en) Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
DE69010217T2 (de) Kieselsäuresole, verfahren zur herstellung von kieselsäuresolen sowie verwendung der sole.
RS51903B (sr) Formulacija aripiprazol kompleksa i postupak
WO2003018752A3 (en) An organotypic intestinal culture and methods of use thereof
DE69917784D1 (de) Flüssige chitosan-enthaltende zusammensetzungen und verfahren zur herstellung und verwendung
ATE556601T1 (de) Zusammensetzung auf basis von vernetzer stärke und depolymerisierter stärke als gelatin-ersatz
ATE487458T1 (de) Verfahren zur verwendung von dentalzusammensetzungen mit fluoreszierenden mitteln
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
BR0204056B1 (pt) mÉtodo de aumento da viscosidade de baixa taxa de cisalhamento e Índice de reduÇço de cisalhamento de fluidos contendo cÁtion divalente e os fluidos obtidos desse modo.
DE69913543T8 (de) Dermales Gerüst auf der Grundlage eines neutralisierten Chitosan-Schwammes oder eines neutralisierten gemischten Chitosan-Kollagen-Schwammes
NO20000425L (no) Kollagen type I og type III klebrende sammensetninger
ATE283893T1 (de) Verwendung von polyorganosiloxan zur verminderung des cold stress whitenings
ATE359343T1 (de) Flüssigkristallzusammensetzung zur verwendung in bistabilen flüssigkristallanzeigen
DE69402951T2 (de) Kombinierten Polymere zur Verwendung in künstlicher Tränenflussigkeit
DE60017997D1 (de) Versiegelungsmaterialzusammensetzung für Karten und Verfahren zur Herstellung von Karten unter Verwendung der Zusammensetzung